drugset / Trial / NCT00864565

A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal System

NCT00864565

Phase 1 Completed 48 enrolled Actavis Inc.
RandomizedCrossoverOpen-label

Summary

To compare the rate and extent of absorption of fentanyl 25 μg/h transdermal system (test) and Duragesic (reference) administrated as 1 x 25 μg/h single transdermal system application.

Timeline

Start
2003-06
Primary completion
2003-06
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 25 ug Other

Indications

No indication recorded.